KP Tissue Statistics
Want to see TSE:KPT full AI Analyst Report?
KP Tissue (KPT) Stock Statistics & Valuation Metrics
Total Valuation
KP Tissue has a market cap or net worth of CAD 124.40M. The enterprise value is CAD 121.99M.
- Market Cap
- CAD 124.40M
- Enterprise Value
- CAD 121.99M
Share Statistics
KP Tissue has 10,032,387 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 10,032,387
- Owned by Insiders
- 0.50%
- Owned by Institutions
- 3.19%
Financial Efficiency
KP Tissue’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 0.00%.
- Return on Equity (ROE)
- 0.12
- Return on Assets (ROA)
- 0.12
- Return on Invested Capital (ROIC)
- 0.00%
- Return on Capital Employed (ROCE)
- 0.00
- Revenue Per Employee
- 0
- Profits Per Employee
- 3,149.63
- Employee Count
- 2,700
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of KP Tissue is 13.76. KP Tissue’s PEG ratio is 0.07.
- PE Ratio
- 13.76
- PS Ratio
- 0.00
- PB Ratio
- 1.73
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.07
Income Statement
In the last 12 months, KP Tissue had revenue of 0 and earned 8.50M in profits. Earnings per share was 0.85.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- 0
- Pretax Income
- 8.50M
- Net Income
- 8.50M
- EBITDA
- 318.23M
- Earnings Per Share (EPS)
- 0.85
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
KP Tissue pays an annual dividend of CAD 0.21, resulting in a dividend yield of 6.37%
- Dividend Per Share
- CAD 0.21
- Dividend Yield
- 6.37%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 7.28%
Stock Price Statistics
- Beta
- 0.36
- 52-Week Price Change
- 28.95%
- 50-Day Moving Average
- 12.09
- 200-Day Moving Average
- 11.71
- Relative Strength Index (RSI)
- 57.46
- Average Volume (3m)
- 15.97K
Important Dates
KP Tissue upcoming earnings date is Mar 11, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 11, 2026
- Next Earnings Date
- Mar 11, 2027
- Ex-Dividend Date
- Jun 30, 2026
Financial Position
KP Tissue as a current ratio of 1.00, with Debt / Equity ratio of 0.00%
- Current Ratio
- 1.00
- Quick Ratio
- 1.00
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.00
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, KP Tissue has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
KP Tissue EV to EBITDA ratio is 0.72, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.72
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
KP Tissue has CAD 0.00 in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of CAD 0.00 billion.
- Cash & Marketable Securities
- CAD 0.00
- Total Debt
- CAD 0.00
- Net Cash
- CAD 0.00
- Net Cash Per Share
- CAD 0.00
- Tangible Book Value Per Share
- CAD 7.09
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for KP Tissue is CAD 13.00, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- CAD 13.00
- Price Target Upside
- 6.12% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 165.83%
Scores
- Smart Score
- 8
- AI Score
- 56

